AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS® FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING Market News
BriaCell Awarded National Cancer Institute Grant to Advance its Bria-OTS Immunotherapy for Cancer Geography
Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market Geography
C4 Therapeutics Announces FDA Clearance of Investigational New Drug Application for CFT8919, an Orally Bioavailable BiDAC Degrader Targeting EGFR L858R for Non-Small Cell Lung Cancer Market News
